The decision paves the way for Enzo to be issued a patent based on its prior application, and the company plans to "rapidly" develop and market products based on the technology for a wide variety of applications.
The suit revolves around patents owned by UNeMed, the technology-transfer organization for the UN Medical Center, and exclusively licensed to Abbot Laboratories, though Abbott is not listed as a co-plaintiff on the complaint.
